Pradimicin therapy of disseminated Candida tropicalis infection in the mouse

M. I. Restrepo, L. K. Najvar, A. W. Fothergill, J. R. Graybill

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

BMS 181184 (BMS), an analogue of pradimicin, was administered intravenously to neutropenic mice infected with either a fluconazole- susceptible or a fluconazole-resistant clinical isolate of Candida tropicalis. BMS prolonged survival at doses >3 mg kg-1 day-1, and at higher doses reduced tissue counts in mice. BMS was less potent mg for mg than amphotericin B. Combined BMS and amphotericin B were no more effective than either of the individual drugs.

Original languageEnglish (US)
Pages (from-to)181-184
Number of pages4
JournalMedical mycology
Volume36
Issue number3
DOIs
Publication statusPublished - Jun 1 1998

    Fingerprint

Keywords

  • BMS
  • Candida tropicalis
  • Fluconazole
  • Mouse model
  • Pradimicin

ASJC Scopus subject areas

  • Infectious Diseases

Cite this